Valuation: BioGaia AB

Market Cap 12.57B 1.27B 1.13B 1.05B 949M 1.79B 120B 1.81B 4.93B 63.06B 4.77B 4.67B 201B P/E 2026 *
32.7x
P/E 2027 * 26.2x
Enterprise Value 11.91B 1.2B 1.07B 993M 899M 1.69B 114B 1.71B 4.67B 59.72B 4.52B 4.42B 190B EV / Sales 2026 *
7.15x
EV / Sales 2027 * 6.32x
Free-Float
80.82%
Yield 2026 *
3.3%
Yield 2027 * 3.52%
1 day+0.08%
1 week+1.56%
Current month+6.71%
1 month+13.14%
3 months+2.99%
6 months+2.06%
Current year+16.76%
1 week 121.3
Extreme 121.3
125.3
1 month 107.8
Extreme 107.8
125.3
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 93.2
Extreme 93.2
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 51.2
Extreme 51.2
139.7
Manager TitleAgeSince
Chief Executive Officer 60 2023-09-29
Director of Finance/CFO 59 2019-11-04
Chief Operating Officer 49 2020-12-31
Director TitleAgeSince
Chairman 77 2002-12-31
Director/Board Member 46 2014-12-31
Director/Board Member 40 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
2/13/26 Buy

Director

582 0.0006%
12/30/25 Buy

General Counsel

390 0.0004%
12/5/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+1.56%+17.31%+27.38% 1.27B
-0.62%+5.44%+59.40%+121.03% 1,144B
-0.84%+1.15%+33.85%+69.65% 625B
-1.66%+0.37%+22.96%+96.59% 511B
+0.54%+5.69%+39.60%+65.02% 377B
+0.96%+1.18%+70.18%+44.28% 366B
+0.30%+3.44%+21.35%+50.15% 291B
-0.03%+2.55%+1.12%+24.89% 262B
+0.24%+3.14%+45.95%+60.96% 237B
-1.52%+0.27%+24.08%+98.50% 194B
Average -0.22%+5.92%+33.58%+65.84% 400.92B
Weighted average by Cap. -0.39%+6.91%+40.80%+81.52%

Financials

2026 *2027 *
Net sales 1.66B 168M 150M 139M 126M 237M 15.88B 240M 653M 8.35B 631M 618M 26.61B 1.89B 191M 170M 157M 142M 268M 17.99B 271M 740M 9.46B 715M 700M 30.14B
Net income 385M 38.92M 34.68M 32.11M 29.06M 54.75M 3.67B 55.4M 151M 1.93B 146M 143M 6.15B 480M 48.53M 43.24M 40.03M 36.23M 68.26M 4.58B 69.07M 188M 2.41B 182M 178M 7.67B
Net Debt -666M -67.28M -59.95M -55.51M -50.23M -94.64M -6.35B -95.76M -261M -3.34B -252M -247M -10.63B -648M -65.46M -58.33M -54M -48.87M -92.08M -6.18B -93.17M -254M -3.25B -246M -240M -10.35B
Projected Income Statement - Annual - BioGaia AB
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
26-10-21 SEK 124.00 -0.24% 136,580
26-10-20 SEK 124.30 -0.08% 154,167
26-10-19 SEK 124.40 +0.40% 119,916
26-10-16 SEK 123.90 +0.90% 263,172
26-10-15 SEK 122.80 +0.57% 209,586
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - BioGaia AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
124.30SEK
Average target price
155.50SEK
Spread / Average Target
+25.10%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BioGaia AB
  1. Stock Market
  2. Stocks
  3. BIOG B Stock